CRIS Current Research Information System

LUNGHI, CARLOTTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.433
NA - Nord America 2.496
EU - Europa 1.447
SA - Sud America 200
Continente sconosciuto - Info sul continente non disponibili 199
AF - Africa 89
OC - Oceania 22
Totale 7.886
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.343
SG - Singapore 957
CN - Cina 916
VN - Vietnam 658
IT - Italia 631
HK - Hong Kong 265
KR - Corea 207
DE - Germania 181
BR - Brasile 153
IN - India 132
SE - Svezia 124
GB - Regno Unito 98
FR - Francia 89
CA - Canada 87
JP - Giappone 71
BD - Bangladesh 70
IE - Irlanda 55
NL - Olanda 53
RU - Federazione Russa 52
FI - Finlandia 40
MX - Messico 33
CI - Costa d'Avorio 29
AT - Austria 26
BG - Bulgaria 26
TH - Thailandia 23
JO - Giordania 21
ID - Indonesia 20
PH - Filippine 20
ZA - Sudafrica 18
AR - Argentina 17
AU - Australia 17
CH - Svizzera 16
ES - Italia 15
PL - Polonia 15
TR - Turchia 15
IQ - Iraq 10
SA - Arabia Saudita 10
TG - Togo 10
PK - Pakistan 9
MA - Marocco 8
TW - Taiwan 7
UA - Ucraina 7
CO - Colombia 6
EC - Ecuador 6
SC - Seychelles 6
CL - Cile 5
CR - Costa Rica 5
JM - Giamaica 5
NG - Nigeria 5
NZ - Nuova Zelanda 5
SV - El Salvador 5
VE - Venezuela 5
BE - Belgio 4
GT - Guatemala 4
HN - Honduras 4
IR - Iran 4
RS - Serbia 4
TT - Trinidad e Tobago 4
DK - Danimarca 3
KE - Kenya 3
PY - Paraguay 3
RO - Romania 3
TN - Tunisia 3
UY - Uruguay 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
EG - Egitto 2
IL - Israele 2
MY - Malesia 2
NI - Nicaragua 2
PS - Palestinian Territory 2
PT - Portogallo 2
SN - Senegal 2
BY - Bielorussia 1
BZ - Belize 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
DZ - Algeria 1
GH - Ghana 1
GP - Guadalupe 1
GY - Guiana 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LY - Libia 1
MM - Myanmar 1
MQ - Martinica 1
PE - Perù 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.689
Salva come PNG Salva come JPEG
Città #
Singapore 656
Hefei 453
San Jose 402
Hong Kong 251
Ashburn 224
Santa Clara 214
Ho Chi Minh City 203
Seoul 199
Hanoi 163
Council Bluffs 162
Boardman 95
Bologna 86
Dallas 73
Beijing 70
Tokyo 63
New York 62
Los Angeles 59
Princeton 57
Lauterbourg 56
Dublin 52
Milan 52
Rome 51
Frankfurt am Main 50
Florence 48
Bengaluru 45
Chandler 37
Southend 30
Abidjan 29
Seattle 27
Helsinki 26
Redondo Beach 26
Sofia 26
Turin 26
Nuremberg 25
Buffalo 24
Da Nang 24
Haiphong 24
Fairfield 23
Montreal 23
São Paulo 22
Amman 21
The Dalles 21
Chicago 20
Des Moines 20
Ann Arbor 19
Modena 17
Jakarta 16
Mexico City 16
Phoenix 16
London 15
Orem 15
Vienna 15
Forlì 14
Woodbridge 14
Tongling 13
Atlanta 12
Bangkok 12
Québec 12
Shanghai 12
Falkenstein 11
Guangzhou 11
Houston 11
Naples 11
Olalla 11
San Diego 11
San Francisco 11
Bern 10
Ha Long 10
Lappeenranta 10
Lomé 10
Warsaw 10
Washington 10
Berlin 9
Cesena 9
Phủ Lý 9
Toronto 9
Wilmington 9
Amsterdam 8
Berkeley 8
Bühl 8
Cambridge 8
Denver 8
Pescara 8
Brakpan 7
Figino 7
Genoa 7
Minneapolis 7
Perth 7
Quận Bình Thạnh 7
Brooklyn 6
Can Tho 6
Embrun 6
Istanbul 6
Medford 6
Mumbai 6
Munich 6
Paris 6
Reggio Emilia 6
Rio de Janeiro 6
Stockholm 6
Totale 4.876
Salva come PNG Salva come JPEG
Nome #
Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals 352
Morbidities and mortality of diagnosed attention deficit hyperactivity disorder (ADHD) over the youth lifespan: A population-based retrospective cohort study 337
Is it time to consider depression as a major complication of type 2 diabetes? Evidence from a large population-based cohort study 284
Deprescribing as a strategy for improving safety of medicines in older people: Clinical and regulatory perspective 202
The interface of depression and diabetes: treatment considerations 194
Association between stimulant and non-stimulant ADHD medications and completed suicide in adolescents and adults: A population-based nested case-control study 187
Prevalence and determinants of long-term utilization of antidepressant drugs: A retrospective cohort study 187
Strategies and Tools for Supporting the Appropriateness of Drug Use in Older People 186
Assessing the environmental impact of medicines in Italy using data from the Italian Medicines Agency 180
Attitudes, barriers, and facilitators toward tools supporting appropriate prescribing among healthcare professionals: a cross-sectional study 174
The environmental impact of pharmaceuticals in Italy: Integrating healthcare and eco-toxicological data to assess and potentially mitigate their diffusion to water supplies 173
Early career researchers’ perspectives and roles in patient-oriented research 162
Leveraging digital medication adherence technologies to enhance sustainability of European health systems: ENABLE's key recommendations 161
SYNHETIC IMMUNOGENIC GLYCOCONJUGATE FOR MELANOMA IMMUNOTHERAPY 155
Comorbidity, trauma, and mortality in children and young adults using ADHD medications in Quebec between 2000 and 2020 153
Psychotropic medication use pre and post-diagnosis of cluster B personality disorder: a Quebec’s health services register cohort 146
ADHD Medication Use and Psychiatric Comorbidity, Trauma and Mortality in Children and Young Adults: A Cohort Study from Quebec, Canada 138
Medical cannabis authorization and risk of emergency department visits and hospitalization due to psychotic disorders: A propensity score-matched cohort study 131
Health care system costs related to potentially inappropriate medication use involving opioids in older adults in Canada 130
Definition and validation of case detection algorithms using Quebec medico-administrative databases (med-echo and ramq) for depression among seniors 127
Cluster B personality disorders and psychotropic medications: a focused analysis of trends and patterns across sex and age groups 123
ADHD medications use and risk of mortality and unintentional injuries: a population-based cohort study 122
Learning of clinical pharmacology by future prescribers in Bologna: Teachers' and students' reflections on the way forward 121
LONG-TERM UTILIZATION OF ANTIDEPRESSANT DRUGS: PREVALENCE AND ASSOCIATED FACTORS 120
Trends in medication use during the COVID-19 pandemic in Quebec, Canada 119
Medication use in the year before and after a diagnosis of cluster B personality disorder: Trends and patterns between 2002 and 2018 in Quebec, Canada 118
Medication use in Italian nursing homes: preliminary results from the national monitoring system 118
What methods are used to study the association between medication adherence trajectories, estimated with the group-based trajectory modeling (GBTM) method, and health-related outcomes?—a protocol for a systematic review 117
What Is the Safety Profile of Cannabis-Based Medications? Analysis of the Post-Marketing Signals from the FDA Adverse Event Reporting System 116
Global prevalence of antidepressant utilization in the community: A protocol for a systematic review 115
Post-marketing safety profile of cannabis products: Signals from the FDA adverse event reporting system 114
Call to action: Pharmaceutical residues in the environment: threats to ecosystems and human health: Pharmaceutical Residues in the Environment: Threats to Ecosystems and Human Health 113
Patient and health system factors associated with potentially inappropriate opioid use in non-cancer community-dwelling older adults 106
Trends in benzodiazepine and alternative hypnotic use in relation with multimorbidity among older adults in Quebec, Canada 104
Psychiatric and non-psychiatric polypharmacy among older adults with schizophrenia: Trends from a population-based study between 2000 and 2016 101
Multimorbidity Treatment Burden Questionnaire (MTBQ): Translation, Cultural Adaptation, and Validation in French-Canadian 94
Environmental sustainability-an essential component of rational use of medicines 92
Trends of polypharmacy among older adults with schizophrenia in Quebec, Canada between 2000 and 2017 87
Environmentally sustainable prescribing: recommendations for EU pharmaceutical legislation 84
Economic evaluations of interventions to optimize medication use in older adults with polypharmacy and multimorbidity: A systematic review 84
Polypharmacy Definitions for Multimorbid Older Adults Need Stronger Foundations to Guide Research, Clinical Practice and Public Health 76
Association Between Depression And Discontinuation With Antidiabetic Drugs 76
Depression and the risk of hospitalization in type 2 diabetes patients: A nested case-control study accounting for non-persistence to antidiabetic treatment 75
Toward the harmonization of bioequivalence guidelines in Europe: Commentary on the state of the art and future priorities under ICH M13A for immediate‐release oral forms 73
Incidence of depression and associated factors in patients with type 2 diabetes in Quebec, Canada 73
Exposure to guideline-recommended drugs after a first acute myocardial infarction in older adults: does deprivation matter? 73
Dosing of Cannabinoids Associated with an Opioid-Sparing Effect: A Systematic Review of Longitudinal Studies 72
Depression but not non-persistence to antidiabetic drugs is associated with mortality in type 2 diabetes: A nested case-control study 72
Scholarly publishing depends on peer reviewers 72
Factors associated with antidiabetic medication non-adherence in patients with incident comorbid depression 68
The delicate choice of optimal basic therapy for multimorbid older adults: A cross-sectional survey 68
Stereoselective synthesis of 1,3-disaccharides through diels-alder reactions: Part 2[ ]: Convenient protecting groups for heterodienes and conformational evaluations 67
The impact of incident depression on medication adherence in patients with type 2 diabetes 67
Prevalence of Depression in Patients with Type 2 Diabetes (T2D) in Quebec 65
Changes in self-rated physical and mental health and life satisfaction associated with opioid and potentially inappropriate opioid prescribing in primary care older adults 64
Sialylexoenitols as precursors for new analogues of sialidase inhibitors 64
null 63
Stable GM3 lactone mimetic raises antibodies specific for the antigens expressed on melanoma cells 63
Benefits, risks and impacts on quality of life of medications used in multimorbid older adults: a Delphi study 63
The Association between Depression and Medication Nonpersistence in New Users of Antidiabetic Drugs 63
Use of Quebec medico-administrative databases for mental health studies: Opportunities, methodological challenges and limitations – The case of depression among diabetic subjects 61
Risk of Psychotic Disorders Among Patients with Medical Cannabis Authorization: A Longitudinal Cohort Study 61
Structural study of liposomes loaded with a GM3 lactone analogue for the targeting of tumor epitopes 60
Risk of Mortality Associated with Potentially Inappropriate Medication Use Including Opioids in Older Adults 59
Alternative mechanistic paths in the Hetero-Diels-Alder reaction of α-oxothiones: A theoretical study 54
CoViD-19 pandemic and incidence of depression in people with diabetes: mental health unmet needs? 54
Utilization of Health Care Services by Patients With Cluster B Personality Disorders or Schizophrenia 54
Treatment sequences in moderate-to-severe psoriasis: a hospital-based retrospective analysis 53
Synthesis, conformational studies, binding assessment and liposome insertion of a thioether-bridged mimetic of the antigen GM3 ganglioside lactone 51
Factors associated with potentially inappropriate opioid use in community-living older adults consulting in primary care 46
Vertigo and Balance Disorders - The Role of Osteopathic Manipulative Treatment: A Systematic Review (vol 23, pg 1, 2020) 25
From adoption to impact: linking prescribing tools to clinical outcomes—authors’ response 4
Totale 7.886
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.795
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.795
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022346 0 0 0 0 2 0 81 41 23 17 102 80
2022/2023519 37 26 35 41 48 22 45 56 105 42 36 26
2023/2024390 23 34 30 22 31 58 30 21 24 51 46 20
2024/20251.705 104 160 134 103 250 89 103 62 54 81 176 389
2025/20264.380 613 641 436 320 299 165 511 208 497 288 214 188
2026/2027533 102 127 287 17 0 0 0 0 0 0 0 0
Totale 7.886